Back
Viking Therapeutics Vs. Structure Therapeutics Industry Stock Comparison
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Buy
71
GPCR
Structure Therapeutics
Last Price:
41.65
Seasonality Move:
4.68%
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $41.75. The Score for GPCR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GPCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $41.75
The current trend is moderately bullish and GPCR is experiencing slight buying pressure.
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 49.26 | Sell |
| Chaikin Money Flow: | -1176939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.9 - 66.32) | Sell |
| Bollinger Bands (100): | (52.14 - 66.8) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 56.84 | Buy |
| Chaikin Money Flow: | 9293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.34 - 41.7) | Buy |
| Bollinger Bands (100): | (34.82 - 45.26) | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.66 | Sell |
| 20-day SMA: | 61.87 | Sell |
| 50-day SMA: | 59.76 | Buy |
| 200-day SMA: | 53.91 | Buy |
| 8-day EMA: | 63.35 | Sell |
| 20-day EMA: | 62.66 | Sell |
| 50-day EMA: | 60.77 | Buy |
| 200-day EMA: | 52.02 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.32 | Buy |
| 20-day SMA: | 39.44 | Buy |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 40.73 | Buy |
| 8-day EMA: | 41.37 | Buy |
| 20-day EMA: | 40.15 | Buy |
| 50-day EMA: | 39.42 | Buy |
| 200-day EMA: | 39.76 | Buy |
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Viking Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||